Review



smac+left scfc  (SMAC Corp)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    SMAC Corp smac+left scfc
    Clinicopathologic features of 28 patients with metaplastic breast carcinoma NACT: neoadjuvant chemotherapy. CT: chemotherapy. RT: radiation therapy. E: estrogen receptor. P:progesterone receptor. H: Her2/neu. Y: Yes. N: No. SCC: squamous cell carcinoma. HGAS: high-grade adenosquamous carcinoma. SpC: spindle cell carcinoma. MCHMD: metaplastic carcinoma with heterologous mesenchymal differentiation. SC: sarcomatoid carcinoma. PR: partial response. SD: stable disease. PD: progressive disease. SMAC: simple mastectomy with axillary clearance. AS: axillary sampling. LM: liver metastasectomy. <t> SCFC: </t> supraclavicular fossa clearance. RM: radical mastectomy. LDF: latissimus dorsi flap. TAF: thoracoabdominal flap. AC: axillary clearance. PCT: palliative chemotherapy. PRT: palliative radiation therapy. DM: distant metastasis. LRR: locoregional recurrence. DOD: died of disease. NED: no evidence of disease. DOOC: died of other causes. AWD: alive with disease.
    Smac+Left Scfc, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/smac+left+scfc/pmc09548328-15-15-15?v=SMAC+Corp
    Average 90 stars, based on 1 article reviews
    smac+left scfc - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Clinicopathologic Features of Metaplastic Breast Carcinoma: Experience From a Tertiary Cancer Center of North India"

    Article Title: Clinicopathologic Features of Metaplastic Breast Carcinoma: Experience From a Tertiary Cancer Center of North India

    Journal: Cureus

    doi: 10.7759/cureus.28978

    Clinicopathologic features of 28 patients with metaplastic breast carcinoma NACT: neoadjuvant chemotherapy. CT: chemotherapy. RT: radiation therapy. E: estrogen receptor. P:progesterone receptor. H: Her2/neu. Y: Yes. N: No. SCC: squamous cell carcinoma. HGAS: high-grade adenosquamous carcinoma. SpC: spindle cell carcinoma. MCHMD: metaplastic carcinoma with heterologous mesenchymal differentiation. SC: sarcomatoid carcinoma. PR: partial response. SD: stable disease. PD: progressive disease. SMAC: simple mastectomy with axillary clearance. AS: axillary sampling. LM: liver metastasectomy. SCFC: supraclavicular fossa clearance. RM: radical mastectomy. LDF: latissimus dorsi flap. TAF: thoracoabdominal flap. AC: axillary clearance. PCT: palliative chemotherapy. PRT: palliative radiation therapy. DM: distant metastasis. LRR: locoregional recurrence. DOD: died of disease. NED: no evidence of disease. DOOC: died of other causes. AWD: alive with disease.
    Figure Legend Snippet: Clinicopathologic features of 28 patients with metaplastic breast carcinoma NACT: neoadjuvant chemotherapy. CT: chemotherapy. RT: radiation therapy. E: estrogen receptor. P:progesterone receptor. H: Her2/neu. Y: Yes. N: No. SCC: squamous cell carcinoma. HGAS: high-grade adenosquamous carcinoma. SpC: spindle cell carcinoma. MCHMD: metaplastic carcinoma with heterologous mesenchymal differentiation. SC: sarcomatoid carcinoma. PR: partial response. SD: stable disease. PD: progressive disease. SMAC: simple mastectomy with axillary clearance. AS: axillary sampling. LM: liver metastasectomy. SCFC: supraclavicular fossa clearance. RM: radical mastectomy. LDF: latissimus dorsi flap. TAF: thoracoabdominal flap. AC: axillary clearance. PCT: palliative chemotherapy. PRT: palliative radiation therapy. DM: distant metastasis. LRR: locoregional recurrence. DOD: died of disease. NED: no evidence of disease. DOOC: died of other causes. AWD: alive with disease.

    Techniques Used: Sampling



    Similar Products

    smac+left scfc  (SMAC Corp)
    90
    SMAC Corp smac+left scfc
    Clinicopathologic features of 28 patients with metaplastic breast carcinoma NACT: neoadjuvant chemotherapy. CT: chemotherapy. RT: radiation therapy. E: estrogen receptor. P:progesterone receptor. H: Her2/neu. Y: Yes. N: No. SCC: squamous cell carcinoma. HGAS: high-grade adenosquamous carcinoma. SpC: spindle cell carcinoma. MCHMD: metaplastic carcinoma with heterologous mesenchymal differentiation. SC: sarcomatoid carcinoma. PR: partial response. SD: stable disease. PD: progressive disease. SMAC: simple mastectomy with axillary clearance. AS: axillary sampling. LM: liver metastasectomy. <t> SCFC: </t> supraclavicular fossa clearance. RM: radical mastectomy. LDF: latissimus dorsi flap. TAF: thoracoabdominal flap. AC: axillary clearance. PCT: palliative chemotherapy. PRT: palliative radiation therapy. DM: distant metastasis. LRR: locoregional recurrence. DOD: died of disease. NED: no evidence of disease. DOOC: died of other causes. AWD: alive with disease.
    Smac+Left Scfc, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/smac+left+scfc/pmc09548328-15-15-15?v=SMAC+Corp
    Average 90 stars, based on 1 article reviews
    smac+left scfc - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Clinicopathologic features of 28 patients with metaplastic breast carcinoma NACT: neoadjuvant chemotherapy. CT: chemotherapy. RT: radiation therapy. E: estrogen receptor. P:progesterone receptor. H: Her2/neu. Y: Yes. N: No. SCC: squamous cell carcinoma. HGAS: high-grade adenosquamous carcinoma. SpC: spindle cell carcinoma. MCHMD: metaplastic carcinoma with heterologous mesenchymal differentiation. SC: sarcomatoid carcinoma. PR: partial response. SD: stable disease. PD: progressive disease. SMAC: simple mastectomy with axillary clearance. AS: axillary sampling. LM: liver metastasectomy. SCFC: supraclavicular fossa clearance. RM: radical mastectomy. LDF: latissimus dorsi flap. TAF: thoracoabdominal flap. AC: axillary clearance. PCT: palliative chemotherapy. PRT: palliative radiation therapy. DM: distant metastasis. LRR: locoregional recurrence. DOD: died of disease. NED: no evidence of disease. DOOC: died of other causes. AWD: alive with disease.

    Journal: Cureus

    Article Title: Clinicopathologic Features of Metaplastic Breast Carcinoma: Experience From a Tertiary Cancer Center of North India

    doi: 10.7759/cureus.28978

    Figure Lengend Snippet: Clinicopathologic features of 28 patients with metaplastic breast carcinoma NACT: neoadjuvant chemotherapy. CT: chemotherapy. RT: radiation therapy. E: estrogen receptor. P:progesterone receptor. H: Her2/neu. Y: Yes. N: No. SCC: squamous cell carcinoma. HGAS: high-grade adenosquamous carcinoma. SpC: spindle cell carcinoma. MCHMD: metaplastic carcinoma with heterologous mesenchymal differentiation. SC: sarcomatoid carcinoma. PR: partial response. SD: stable disease. PD: progressive disease. SMAC: simple mastectomy with axillary clearance. AS: axillary sampling. LM: liver metastasectomy. SCFC: supraclavicular fossa clearance. RM: radical mastectomy. LDF: latissimus dorsi flap. TAF: thoracoabdominal flap. AC: axillary clearance. PCT: palliative chemotherapy. PRT: palliative radiation therapy. DM: distant metastasis. LRR: locoregional recurrence. DOD: died of disease. NED: no evidence of disease. DOOC: died of other causes. AWD: alive with disease.

    Article Snippet: 15. , 67 , F , T4bN3c , MCHMD , E+P+H- , Y, PR , SMAC+Left SCFC , ypT3N1 , Y , N , --- , --- , DOOC.

    Techniques: Sampling